Insider Transactions in Q4 2024 at Cardiff Oncology, Inc. (CRDF)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 18
2024
|
James E. Levine Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
2,400
+3.42%
|
$12,000
$5.0 P/Share
|
|
Dec 17
2024
|
James E. Levine Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
2,752
+4.04%
|
$13,760
$5.42 P/Share
|
|
Dec 16
2024
|
James E. Levine Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
2,564
+3.94%
|
$7,692
$3.83 P/Share
|
|
Dec 12
2024
|
Renee P Tannenbaum |
BUY
Open market or private purchase
|
Direct |
10,000
+33.33%
|
$30,000
$3.42 P/Share
|
|
Dec 11
2024
|
Gary W Pace |
BUY
Open market or private purchase
|
Indirect |
11,500
+1.07%
|
$23,000
$2.6 P/Share
|
|
Dec 11
2024
|
Gary W Pace |
BUY
Open market or private purchase
|
Direct |
350,115
+25.04%
|
$700,230
$2.6 P/Share
|